Foundayo and Birth Control: What the FDA Label Says About Oral Contraceptives

If you rely on oral birth control pills and are starting — or considering — Foundayo (orforglipron), there is a critical drug interaction you need to understand. The FDA-approved prescribing information explicitly warns that Foundayo can reduce the effectiveness of oral hormonal contraceptives by slowing gastric emptying and altering drug absorption. This is not a theoretical concern; it is printed on the label.

This guide breaks down exactly what the FDA says, how long the risk lasts, which contraceptive methods are safe during Foundayo therapy, and what to do if you become pregnant while taking the medication.

How Foundayo Affects Oral Contraceptives

Foundayo is a once-daily oral GLP-1 receptor agonist. Like other GLP-1 medications, it works in part by delaying gastric emptying — food and other substances stay in your stomach longer before moving to the small intestine where absorption occurs. This mechanism is central to how Foundayo suppresses appetite and controls blood sugar.

The problem is that oral contraceptive pills depend on predictable, rapid absorption in the small intestine to maintain the steady hormone levels needed to prevent ovulation. When gastric emptying is delayed, the rate and extent of absorption of oral hormones can change — potentially dropping below the threshold needed for reliable contraception.

This interaction applies to both combined oral contraceptives (estrogen + progestin) and progestin-only pills (the "mini-pill"), which are particularly sensitive to timing and absorption consistency.

What the FDA Label Actually Says

The Foundayo prescribing information is specific and unambiguous:

• Patients should use an alternative non-oral contraceptive method OR add a barrier method (such as condoms) for 30 days after initiating Foundayo.
• Patients should use an alternative non-oral contraceptive method OR add a barrier method for 30 days after each dose increase.

This is not a one-time precaution. The Foundayo titration schedule involves multiple dose increases — from 0.8 mg up to the maintenance dose of 17.2 mg — over a period of approximately 20 weeks. That means you may need backup contraception for five or more months while your dose is being adjusted.

Here is a practical timeline showing how this plays out:

• Weeks 1–4: Start 0.8 mg → need backup contraception for 30 days
• Week 5: Increase to next dose → restart the 30-day backup clock
• Week 9: Another increase → restart 30-day clock again
• This pattern repeats through every titration step until you reach and stabilize at your maintenance dose

In practice, this means that if you rely solely on the pill, you need backup protection for essentially the entire titration period.

Which Contraceptive Methods Are Affected?

Not all contraceptive methods are absorbed through the GI tract. The following table shows which methods are affected by Foundayo's impact on gastric emptying and which remain reliable.

Contraceptive Method	Route	Affected by Foundayo?	Notes
Combined Oral Contraceptive Pill	Oral	Yes	Absorption may be reduced; backup required
Progestin-Only Pill (Mini-Pill)	Oral	Yes	Especially sensitive to absorption timing
Hormonal IUD (Mirena, Kyleena, Liletta)	Intrauterine	No	Local hormone release; not GI-dependent
Copper IUD (Paragard)	Intrauterine	No	Non-hormonal; highly effective
Implant (Nexplanon)	Subdermal	No	Effective for up to 3 years
Contraceptive Patch (Xulane)	Transdermal	No	Absorbed through the skin
Vaginal Ring (NuvaRing)	Vaginal	No	Local vaginal absorption
Injectable (Depo-Provera)	Intramuscular	No	Administered every 12–13 weeks
Male/Female Condoms	Barrier	No	Recommended as adjunct during titration

Safe Contraceptive Alternatives During Foundayo Therapy

For women starting Foundayo who want reliable contraception without worrying about absorption issues, these non-oral options bypass the GI tract entirely:

• Intrauterine Devices (IUDs) — Both hormonal (Mirena, Kyleena, Liletta) and copper (Paragard) are highly effective, long-acting, and completely unaffected by gastric emptying changes. An IUD is often the simplest solution if you plan to be on Foundayo long-term.
• Subdermal Implant (Nexplanon) — A small rod placed under the skin of the upper arm, effective for up to 3 years. One of the most effective contraceptive methods available.
• Contraceptive Patch (Xulane) — Applied to the skin weekly, delivers hormones transdermally. Not affected by GI absorption.
• Vaginal Ring (NuvaRing) — Inserted monthly, releases hormones locally through the vaginal mucosa.
• Injectable (Depo-Provera) — Administered as an intramuscular injection every 12–13 weeks. Completely bypasses the digestive system.
• Barrier Methods (Condoms) — Should be used as a supplement during the titration period if switching from oral contraceptives isn't immediate.

Risk of Fetal Harm

The FDA label states that Foundayo "may cause fetal harm." Animal reproduction studies with orforglipron showed adverse developmental effects at clinically relevant exposures. No adequate and well-controlled studies have been conducted in pregnant women.

If pregnancy is recognized while taking Foundayo, the medication should be discontinued immediately. Continued exposure during pregnancy is not recommended under any circumstances.

Eli Lilly has established a Pregnancy Exposure Registry to monitor outcomes in women who become pregnant during or shortly after Foundayo treatment. Healthcare providers and patients can contact the registry at 1-800-LillyRx (1-800-545-5979). Enrollment helps gather data that informs future safety guidance.

Practical Recommendations

If you are a woman of reproductive potential starting Foundayo, here is what to do:

• Talk to your prescriber before starting — discuss your current contraceptive method and whether it needs to change.
• Switch to a non-oral method if possible — an IUD, implant, or injectable eliminates the absorption concern entirely.
• If staying on the pill, use condoms — for at least 30 days after each dose change. Be consistent.
• Do not assume you are protected just because you take your pill at the same time every day. Foundayo's effect on absorption is pharmacological, not a matter of timing.
• Take a pregnancy test if you miss a period or experience unusual symptoms — early detection matters.
• Read the related guide on Foundayo and Pregnancy for detailed information about what happens if you become pregnant.

The Bottom Line

Foundayo's interaction with oral contraceptives is a well-documented, FDA-labeled concern — not speculation. If you rely on the pill for birth control, you will need backup protection for months during titration. The simplest long-term solution is switching to a non-oral contraceptive method before or shortly after starting Foundayo. Discuss your options with your healthcare provider.

Medical Disclaimer: This article is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before starting, stopping, or changing any medication or contraceptive method. The information presented reflects current FDA labeling and clinical data as of the publication date. Individual circumstances may vary.